Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Quarterly Results - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573|NSE: APLLTD|ISIN: INE901L01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 11, 16:00
574.45
-3.2 (-0.55%)
VOLUME 2,346
LIVE
NSE
Nov 11, 16:00
574.25
-2.8 (-0.49%)
VOLUME 42,804
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Consolidated Quarterly Results of Alembic Pharmaceuticals

------------------- in Rs. Cr. -------------------
Sep '19 Jun '19 Mar '19 Dec '18 Sep '18
Net Sales/Income from operations 1,240.87 948.91 926.95 1,018.15 1,127.06
Other Operating Income -- -- -- -- --
Total Income From Operations 1,240.87 948.91 926.95 1,018.15 1,127.06
EXPENDITURE
Consumption of Raw Materials 239.77 232.01 206.84 201.72 239.83
Purchase of Traded Goods 95.22 81.97 68.53 46.16 64.59
Increase/Decrease in Stocks -62.37 -109.58 -58.63 0.58 -32.37
Power & Fuel -- -- -- -- --
Employees Cost 217.75 214.87 200.74 198.40 182.62
Depreciation 35.95 35.40 29.95 29.05 28.63
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 404.98 304.72 331.43 329.06 370.05
P/L Before Other Inc., Int., Excpt. Items & Tax 309.57 189.52 148.09 213.18 273.71
Other Income 0.36 3.29 3.37 3.52 2.37
P/L Before Int., Excpt. Items & Tax 309.93 192.81 151.46 216.70 276.08
Interest 7.07 4.98 5.08 5.95 5.81
P/L Before Exceptional Items & Tax 302.86 187.83 146.38 210.75 270.27
Exceptional Items -- -32.79 -- -- --
P/L Before Tax 302.86 155.04 146.38 210.75 270.27
Tax 52.49 35.96 14.90 40.00 70.30
P/L After Tax from Ordinary Activities 250.37 119.08 131.48 170.75 199.97
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 250.37 119.08 131.48 170.75 199.97
Minority Interest -- -- -- 0.77 -0.02
Share Of P/L Of Associates 0.08 0.41 -7.78 -1.69 0.12
Net P/L After M.I & Associates 250.45 119.49 123.70 169.83 200.07
Equity Share Capital 37.70 37.70 37.70 37.70 37.70
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 13.06 6.56 6.58 9.01 10.61
Diluted EPS 13.06 6.56 6.58 9.01 10.61
EPS After Extra Ordinary
Basic EPS 13.06 6.56 6.58 9.01 10.61
Diluted EPS 13.06 6.56 6.58 9.01 10.61
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for alembicpharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.